DHEA, Androgen Receptors, and Their Potential Role in Breast Cancer

2011 ◽  
pp. 273-282
Keyword(s):  
Breast Cancer ◽  
Potential Role ◽  
Androgen Receptors

A systematic review of long non-coding RNAs with a potential role in Breast Cancer

2021 ◽  
pp. 108375
Author(s):  
Reza Heidari ◽  
Mostafa Akbariqomi ◽  
Yazdan Asgari ◽  
Diako Ebrahimi ◽  
Hamid Alinejad-Rokny
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Potential Role ◽  
Non Coding Rnas

The potential role of ERβ isoforms in the clinical management of breast cancer

2008 ◽  
Vol 53 (4) ◽  
pp. 374-380 ◽  
Author(s):  
C A Green ◽  
M B Peter ◽  
V Speirs ◽  
A M Shaaban
Keyword(s):  
Breast Cancer ◽  
Clinical Management ◽  
Potential Role

scholarly journals The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs)

2022 ◽  
Vol 15 (1) ◽  
pp. 101247
Author(s):  
Jane Howard ◽  
Chia Yin Goh ◽  
Karolina Weiner Gorzel ◽  
Michaela Higgins ◽  
Amanda McCann
Keyword(s):  
Breast Cancer ◽  
Extracellular Vesicles ◽  
Triple Negative Breast Cancer ◽  
Potential Role ◽  
Triple Negative

Identification of non-invasive biomarkers for early detection of breast cancer: A Review

2021 ◽  
Vol 2 (1) ◽  
pp. 01-05
Author(s):  
Asima Tayyab
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Potential Role ◽  
Small Volume ◽  
Breast Cancer Diagnosis ◽  
Diagnostic Purpose ◽  
Diagnose Breast Cancer ◽  
Non Invasive ◽  
Early Stages

Despite decades of research, diagnostic tests with specificity and accuracy for early breast cancer are yet unavailable. Major problems associated with poor diagnosis are either due to incompetency of reported biomarkers or small volume of patients under study. Moreover, heterogeneity of the disease further complicates the struggle of identifying effective biomarkers. Therefore, to improve the survival rate, look for new, sensitive and specific biomarkers for early breast cancer diagnosis is need of hour. In this study, we have reviewed recently reported serum biomarkers and categorized them based on their biomolecular nature such as protein, ctDNA, epigenetics regulation and miRNA. Potential role of these available biomarkers in early diagnosis of breast cancer has also been discussed. Based on the facts obtained from literature review, it is revealed that using any individual biomolecule as a biomarker is not sufficient to diagnose breast cancer at early stages rather it is suggested that a panel of proteins or miRNAs would offer better sensitivity and specificity. Whereas, unavailability of a potential ctDNA and epigenetics regulation candidate for diagnostic purpose is and suggest the use of more sophisticated techniques to unwound these regulations in serum especially at early stages of breast cancer.

Sign in / Sign up

Export Citation Format

Share Document